Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
AstraZeneca
McKinsey
Farmers Insurance
Teva
Fish and Richardson
UBS
US Department of Justice
Citi

Generated: June 19, 2018

DrugPatentWatch Database Preview

Ticlopidine hydrochloride - Generic Drug Details

or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for ticlopidine hydrochloride and what is the scope of ticlopidine hydrochloride patent protection?

Ticlopidine hydrochloride
is the generic ingredient in two branded drugs marketed by Roche Palo, Actavis Elizabeth, Apotex, Mylan, Sun Pharm Inds Inc, Teva, Watson Labs, and Yaopharma Co Ltd, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for ticlopidine hydrochloride. Two suppliers are listed for this compound.
Pharmacology for ticlopidine hydrochloride
Synonyms for ticlopidine hydrochloride
4-C-32
5-(2-chloro-benzyl)-4,5,6,7-tetrahydro-thieno[3,2-c]pyridine hydrochloride
5-(2-chloro-benzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride
5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride
5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno-(3,2-c)pyridine hydrochloride
5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium chloride
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno [3,2-c] pyridine hydrochloride
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride
5-[(2-chlorophenyl)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridine hydrochloride
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine hydrochloride
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine;hydrochloride
5-[o-Chlorobenzyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
53-32C
53885-35-1
885T351
A1L4914FMF
AB0008390
AB2000404
AC-8973
AC1L232P
AK-82274
AKOS015905580
AN-7470
API0004830
Aplaket
AS-10890
BB_SC-2114
BCP0726000288
BG0339
C14H14ClNS.HCl
C14H15Cl2NS
CCG-101023
CHEBI:9589
CHEMBL1717
CPD000048468
CS-1985
CTK8E8327
D01028
DTXSID80202141
EINECS 258-837-4
FT-0630664
HMS1568I15
HY-B0153A
J10052
KB-81153
KS-00000XKJ
LS-152431
M-1277
MFCD00079606
MLS000028579
MLS000083578
MLS001401394
MolPort-003-666-728
MTKNGOHFNXIVOS-UHFFFAOYSA-N
NC00273
NSC-759165
NSC759165
Opera_ID_1799
Panaldine
Pharmakon1600-01505677
Prestwick_502
PubChem22095
s1984
SAM001246558
SC-13802
SCHEMBL33596
SMR000048468
ST24044168
TC-030494
Thieno(3,2-c)pyridine, 4,5,6,7-tetrahydro-5-(o-chlorobenzyl)-, hydrochloride
Thieno(3,2-c)pyridine, 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydro-, hydrochloride
Ticlid
Ticlid (TN)
Ticlodix
Ticlodone
Ticlopidine (hydrochloride)
Ticlopidine HCL
Ticlopidine hydrochloride (JP17/USAN)
Ticlopidine hydrochloride [USAN:JAN]
Ticlopidine hydrochloride [USAN:USP:JAN]
Ticlopidine hydrochloride, analytical standard, for drug analysis
Ticlopidine hydrochloride, European Pharmacopoeia (EP) Reference Standard
Ticlopidine hydrochloride, United States Pharmacopeia (USP) Reference Standard
TiclopidineHydrochloride
Tiklid
Tiklyd
Triclopidine hydrochloride
UNII-A1L4914FMF
VA11875
W-105699

US Patents and Regulatory Information for ticlopidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075089-001 Jul 1, 1999 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Yaopharma Co Ltd TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075318-001 Aug 20, 1999 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Inc TICLOPIDINE HYDROCHLORIDE ticlopidine hydrochloride TABLET;ORAL 075526-001 Sep 26, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for ticlopidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 ➤ Sign Up ➤ Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-002 Oct 31, 1991 ➤ Sign Up ➤ Sign Up
Roche Palo TICLID ticlopidine hydrochloride TABLET;ORAL 019979-001 Mar 24, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Farmers Insurance
Deloitte
Dow
Boehringer Ingelheim
US Department of Justice
AstraZeneca
Fish and Richardson
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.